Search For "bharat biotech"
Bharat Biotech completes clinical development for phase III trials, booste
Updated : 3 years, 7 months ago IST
Hyderabad (Telangana) [India], August 15 (ANI): Bharat Biotech International on Monday said that BBV154 (intranasal vaccine) has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials.
Read More
Japan approves COVAXIN booster dose for travellers: Bharat Biotech
Updated : 3 years, 7 months ago IST
Hyderabad [Telangana], August 5 (ANI): Hyderabad-based Bharat Biotech on Friday announced that Japan has approved the COVAXIN booster dose for travellers.
Read More
Covaxin booster dose increases immune response by 40 times, gives long-ter
Updated : 3 years, 8 months ago IST
Hyderabad (Telangana) [India], July 20 (ANI): Hyderabad-based Bharat Biotech on Wednesday announced that the administration of the third dose of its COVID-19 vaccine Covaxin (BBV152) after six months of two-dose vaccination dramatically increased neutralizing antibody responses against both
Read More
NTAGI approves Corbevax, Covaxin for 5-12 yrs age group: Sources
Updated : 3 years, 8 months ago IST
New Delhi [India], July 8 (ANI): The National Technical Advisory Group on Immunisation's (NTAGI) Standing Technical Sub-Committee (STSC) has given a nod for the use of Biological E's Corbevax and Bharat Biotech's Covaxin for children aged between 5-12 years, sources informed on Friday.
Read More
Bharat Biotech's COVID-19 nasal vaccine phase III trials completed
Updated : 3 years, 9 months ago IST
Paris [France], June 19 (ANI): Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday (local time) said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller General of India (DCG
Read More
Covaxin safe for children aged 2-18 years, says Bharat Biotech
Updated : 3 years, 9 months ago IST
Hyderabad (Telangana) [India], June 17 (ANI): Bharat Biotech International Limited (BBIL) on Thursday announced that Covaxin, its whole-virion inactivated COVID-19 vaccine has proven to be safe, well-tolerated, and highly immunogenic in paediatric subjects in phase II/III study, said a press
Read More
PM Modi to inaugurate Biotech Startup Expo 2022 today
Updated : 3 years, 9 months ago IST
New Delhi [India], June 9 (ANI): Prime Minister Narendra Modi will inaugurate the Biotech Startup Expo - 2022 at Pragati Maidan, New Delhi today at 10:30 am.
Read More
Germany to recognize Bharat Biotech's COVAXIN for travel from June 1
Updated : 3 years, 10 months ago IST
New Delhi [India], May 26 (ANI): German Ambassador to India, Walter J Lindner, on Thursday hailed the German government for recognizing the WHO-listed Bharat Biotech's COVID vaccine, COVAXIN, for travel to the country starting June 1.
Read More
FDA removes hold on clinical trial for phase 2,3 for COVAXIN-BBV152 says
Updated : 3 years, 10 months ago IST
Malvern (Pennsylvania) [US], May 23 (ANI): Biotechnology company Ocugen on Monday announced that the US Food and Drug Administration (FDA) lifted the clinical hold on the Company's Phase 2, 3 clinical trials for COVAXIN™ (BBV152).
Read More
CEPI partners with Bharat Biotech, University of Sydney, ExcellGene to dev
Updated : 3 years, 10 months ago IST
Oslo [Norway], May 10 (ANI): The Coalition for Epidemic Preparedness Innovations (CEPI) on Tuesday announced the latest award under its USD 200 m programme to advance the development of vaccines that provide broad protection against SARS-Cov-2 variants and other beta coronaviruses.
Read More
Bharat Biotech seeks DCGI's permission to conduct Covaxin booster trials i
Updated : 3 years, 10 months ago IST
New Delhi [India], May 4 (ANI): Hyderabad-based pharma company Bharat Biotech has sought permission from the Drugs Controller General of India (DCGI) to conduct trials of Covaxin as COVID-19 vaccine booster dose in the 2-18 age group, sources said.
Read More
'Portrays incorrect picture', MEA on reports of it asking Bharat Biotech t
Updated : 3 years, 11 months ago IST
New Delhi [India], April 29 (ANI): The Minstry of External Affairs has said that media reports purportedly quoting a communication from the ministry asking vaccine maker Bharat Biotech to address issues to avoid cancellation of WHO's emergency use approval (EUA) nod for its COVID jab, "potra
Read More